Author/Authors :
جليليان، اميرضا نويسنده Radiopharmaceutical Research and Development Lab, Nuclear Science and Technology Research Institute, Atomic Energy Organization of Iran, Tehran, Iran Jalilian, Amir Reza , حسيني، محمدامين نويسنده Radiopharmaceutical Research and Development Lab, Nuclear Science and Technology Research Institute, Atomic Energy Organization of Iran, Tehran, Iran Hosseini, Hosseini , بلوري نوين، فاطمه نويسنده سازمان انرژي اتمي ايران,پژوهشگاه علوم و فنون هسته اي ,
Abstract :
Introduction: In order to develop a radiolabeled calcitonin (CT) derivative for receptor imaging studies, CT
was successively labeled with 67Ga-gallium chloride.
Methods: The best results of the conjugation were obtained by the addition of 0.5 ml of a CT nasal
pharmaceutical solution (1100 IU) to a glass tube pre-coated with DTPA-dianhydride (0.01 mg) at 25?C with
continuous mild stirring for 30 min.
Results: After solid phase purification of the radiolabeled hormone, instant thin layer chromatography (ITLC)
showed radiochemical purity of higher than 95 % at optimized conditions (specific activity =67-134 KBq/IU,
labeling efficiency 70%). 67Ga-DTPA-CT mainly accumulates in the liver.
Conclusion: Preliminary in vivo studies (ID/g%) in male wild-type rats showed significant liver uptake of the
tracer after 24 hours. 67Ga-DTPA-CT can be a suitable probe for biodistribution study of CT receptors in various
physiological as well as neoplastic lesions with over-expressed calcitonin receptors.